187 related articles for article (PubMed ID: 37652022)
1. The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.
McGurk KA; Zhang X; Theotokis P; Thomson K; Harper A; Buchan RJ; Mazaika E; Ormondroyd E; Wright WT; Macaya D; Pua CJ; Funke B; MacArthur DG; Prasad SK; Cook SA; Allouba M; Aguib Y; Yacoub MH; O'Regan DP; Barton PJR; Watkins H; Bottolo L; Ware JS
Am J Hum Genet; 2023 Sep; 110(9):1482-1495. PubMed ID: 37652022
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population.
Bourfiss M; van Vugt M; Alasiri AI; Ruijsink B; van Setten J; Schmidt AF; Dooijes D; Puyol-Antón E; Velthuis BK; van Tintelen JP; Te Riele ASJM; Baas AF; Asselbergs FW
Circ Genom Precis Med; 2022 Dec; 15(6):e003704. PubMed ID: 36264615
[TBL] [Abstract][Full Text] [Related]
3. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.
Jansen M; de Brouwer R; Hassanzada F; Schoemaker AE; Schmidt AF; Kooijman-Reumerman MD; Bracun V; Slieker MG; Dooijes D; Vermeer AMC; Wilde AAM; Amin AS; Lekanne Deprez RH; Herkert JC; Christiaans I; de Boer RA; Jongbloed JDH; van Tintelen JP; Asselbergs FW; Baas AF
JACC Heart Fail; 2024 Jan; 12(1):134-147. PubMed ID: 37565978
[TBL] [Abstract][Full Text] [Related]
4. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
[TBL] [Abstract][Full Text] [Related]
5. Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
Shah RA; Asatryan B; Sharaf Dabbagh G; Aung N; Khanji MY; Lopes LR; van Duijvenboden S; Holmes A; Muser D; Landstrom AP; Lee AM; Arora P; Semsarian C; Somers VK; Owens AT; Munroe PB; Petersen SE; Chahal CAA;
Circulation; 2022 Jul; 146(2):110-124. PubMed ID: 35708014
[TBL] [Abstract][Full Text] [Related]
6. Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy.
Puckelwartz MJ; Pesce LL; Dellefave-Castillo LM; Wheeler MT; Pottinger TD; Robinson AC; Kearns SD; Gacita AM; Schoppen ZJ; Pan W; Kim G; Wilcox JE; Anderson AS; Ashley EA; Day SM; Cappola T; Dorn GW; McNally EM
J Am Heart Assoc; 2021 Apr; 10(7):e019944. PubMed ID: 33764162
[TBL] [Abstract][Full Text] [Related]
7. TCAP gene is not a common cause of cardiomyopathy in Iranian patients.
Alaei Z; Zamani N; Rabbani B; Mahdieh N
Eur J Med Res; 2023 Sep; 28(1):376. PubMed ID: 37752589
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
de Marvao A; McGurk KA; Zheng SL; Thanaj M; Bai W; Duan J; Biffi C; Mazzarotto F; Statton B; Dawes TJW; Savioli N; Halliday BP; Xu X; Buchan RJ; Baksi AJ; Quinlan M; Tokarczuk P; Tayal U; Francis C; Whiffin N; Theotokis PI; Zhang X; Jang M; Berry A; Pantazis A; Barton PJR; Rueckert D; Prasad SK; Walsh R; Ho CY; Cook SA; Ware JS; O'Regan DP
J Am Coll Cardiol; 2021 Sep; 78(11):1097-1110. PubMed ID: 34503678
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy.
Topriceanu CC; Pereira AC; Moon JC; Captur G; Ho CY
Circulation; 2024 Jan; 149(2):107-123. PubMed ID: 37929589
[TBL] [Abstract][Full Text] [Related]
10. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
[TBL] [Abstract][Full Text] [Related]
11. Genomic findings of hypertrophic and dilated cardiomyopathy characterized in a Thai clinical genetics service.
Trachoo O; Yingchoncharoen T; Ngernsritrakul T; Iemwimangsa N; Panthan B; Klumsathian S; Srisukh S; Mukdadilok A; Phusanti S; Charoenyingwattana A; Chareonsirisuthigul T; Chantratita W; Tangcharoen T
PLoS One; 2022; 17(9):e0267770. PubMed ID: 36166435
[TBL] [Abstract][Full Text] [Related]
12. Genetic variant burden and adverse outcomes in pediatric cardiomyopathy.
Burstein DS; Gaynor JW; Griffis H; Ritter A; Connor MJO; Rossano JW; Lin KY; Ahrens-Nicklas RC
Pediatr Res; 2021 May; 89(6):1470-1476. PubMed ID: 32746448
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.
Aljeaid D; Sanchez AI; Wakefield E; Chadwell SE; Moore N; Prada CE; Zhang W
Am J Med Genet A; 2019 Apr; 179(4):608-614. PubMed ID: 30762279
[TBL] [Abstract][Full Text] [Related]
14. Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies.
Mazzarotto F; Hawley MH; Beltrami M; Beekman L; de Marvao A; McGurk KA; Statton B; Boschi B; Girolami F; Roberts AM; Lodder EM; Allouba M; Romeih S; Aguib Y; Baksi AJ; Pantazis A; Prasad SK; Cerbai E; Yacoub MH; O'Regan DP; Cook SA; Ware JS; Funke B; Olivotto I; Bezzina CR; Barton PJR; Walsh R
Genet Med; 2021 May; 23(5):856-864. PubMed ID: 33500567
[TBL] [Abstract][Full Text] [Related]
15. Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy.
Mak TSH; Lee YK; Tang CS; Hai JSH; Ran X; Sham PC; Tse HF
Sci Rep; 2018 Jul; 8(1):10846. PubMed ID: 30022097
[TBL] [Abstract][Full Text] [Related]
16. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy.
Hayashi T; Arimura T; Itoh-Satoh M; Ueda K; Hohda S; Inagaki N; Takahashi M; Hori H; Yasunami M; Nishi H; Koga Y; Nakamura H; Matsuzaki M; Choi BY; Bae SW; You CW; Han KH; Park JE; Knöll R; Hoshijima M; Chien KR; Kimura A
J Am Coll Cardiol; 2004 Dec; 44(11):2192-201. PubMed ID: 15582318
[TBL] [Abstract][Full Text] [Related]
17. Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden.
Ricci F; Banihashemi B; Pirouzifard M; Sundquist J; Sundquist K; Sutton R; Fedorowski A; Zöller B
ESC Heart Fail; 2023 Feb; 10(1):121-132. PubMed ID: 36169166
[TBL] [Abstract][Full Text] [Related]
18. Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies.
Walsh R; Offerhaus JA; Tadros R; Bezzina CR
Nat Rev Cardiol; 2022 Mar; 19(3):151-167. PubMed ID: 34526680
[TBL] [Abstract][Full Text] [Related]
19. Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.
Biddinger KJ; Jurgens SJ; Maamari D; Gaziano L; Choi SH; Morrill VN; Halford JL; Khera AV; Lubitz SA; Ellinor PT; Aragam KG
JAMA Cardiol; 2022 Jul; 7(7):715-722. PubMed ID: 35583889
[TBL] [Abstract][Full Text] [Related]
20. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals.
Salazar-Mendiguchía J; Barriales-Villa R; Lopes LR; Ochoa JP; Rodríguez-Vilela A; Palomino-Doza J; Larrañaga-Moreira JM; Cicerchia M; Cárdenas-Reyes I; García-Giustiniani D; Brögger N; Fernández G; García S; Santiago L; Vélez P; Ortiz-Genga M; Elliott PM; Monserrat L
Eur J Med Genet; 2020 Dec; 63(12):104079. PubMed ID: 33035702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
